Literature DB >> 12107085

Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells.

Ronald J C L M Vuylsteke1, Paul A M van Leeuwen, Sybren Meijer, Pepijn G J T B Wijnands, Markwin G Statius Muller, Dirk H Busch, Rik J Scheper, Tanja D de Gruijl.   

Abstract

Immune responses against tumor antigens will initially occur in the first tumor-draining lymph node, the sentinel node (SN). Because of extensive diagnostic procedures, obtaining a piece of SN to isolate viable immune cells for functional analyses is often impossible. For this reason an alternative method to obtain viable cells from a lymph node (LN) was investigated, ie, scraping LNs with a surgical blade, and compared with dissociation of total LNs. Tumor-draining lymph nodes were retrieved from five oncological patients. The collected dendritic cells and T cells were phenotypically and functionally characterized by flow cytometry and antigen-specific interferon (IFN)-gamma release in an ELISPOT assay. Results were compared between the two isolation methods. Viabilities and phenotypic characteristics of the collected cells were entirely comparable for both methods. T-cell functionality was also comparable between both methods, with equal T-cell expansion factors and similar frequencies of cytotoxic T cells specifically recognizing the M1 matrix protein of Influenza haemophilus or the tumor antigen Her-2/neu. In conclusion, scraping LNs to obtain cells for analysis of immune functions in LNs is feasible and presents a good alternative to dissociation of LNs. Scraping may even be applied to small LNs that a pathologist will submit entirely for histological examination and may thus prove useful in the monitoring of immune responses in SNs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107085      PMCID: PMC1850698          DOI: 10.1016/S0002-9440(10)64152-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

Review 1.  The dendritic cell system and its role in immunogenicity.

Authors:  R M Steinman
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

Review 2.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

Review 3.  Origin, maturation and antigen presenting function of dendritic cells.

Authors:  M Cella; F Sallusto; A Lanzavecchia
Journal:  Curr Opin Immunol       Date:  1997-02       Impact factor: 7.486

4.  Intraoperative immunocytochemistry of cytologic scrape specimens. A rapid immunoperoxidase method for triage and diagnosis.

Authors:  D J Dabbs; L Hafer; C S Abendroth
Journal:  Acta Cytol       Date:  1995 Mar-Apr       Impact factor: 2.319

5.  Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix.

Authors:  T D de Gruijl; H J Bontkes; A J van den Muysenberg; J W van Oostveen; M J Stukart; R H Verheijen; N van der Vange; P J Snijders; C J Meijer; J M Walboomers; R J Scheper
Journal:  Eur J Cancer       Date:  1999-03       Impact factor: 9.162

6.  Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.

Authors:  A E Chang; A Aruga; M J Cameron; V K Sondak; D P Normolle; B A Fox; S Shu
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

7.  Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood.

Authors:  A Schmittel; U Keilholz; C Scheibenbogen
Journal:  J Immunol Methods       Date:  1997-12-29       Impact factor: 2.303

8.  Comparison of two methods of mechanical disaggregation of scirrhous breast adenocarcinomas for DNA flow cytometric analysis of whole cells.

Authors:  F X Torres; P G Mackowiak; R D Brown; M D Linden; R J Zarbo
Journal:  Am J Clin Pathol       Date:  1995-01       Impact factor: 2.493

9.  Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy.

Authors:  H van der Veen; O S Hoekstra; M A Paul; M A Cuesta; S Meijer
Journal:  Br J Surg       Date:  1994-12       Impact factor: 6.939

10.  Tumor-specific granulocyte/macrophage colony-stimulating factor and interferon gamma secretion is associated with in vivo therapeutic efficacy of activated tumor-draining lymph node cells.

Authors:  A Aruga; S Shu; A E Chang
Journal:  Cancer Immunol Immunother       Date:  1995-11       Impact factor: 6.968

View more
  11 in total

1.  Dendritic cell modification of neutrophil responses to infection after burn injury.

Authors:  Julia Bohannon; Weihua Cui; Edward Sherwood; Tracy Toliver-Kinsky
Journal:  J Immunol       Date:  2010-08-02       Impact factor: 5.422

2.  Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells.

Authors:  Barbara G Molenkamp; Ronald J C L M Vuylsteke; Paul A M van Leeuwen; Sybren Meijer; Wim Vos; Pepijn G J T B Wijnands; Rik J Scheper; Tanja D de Gruijl
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

3.  Selective transduction of mature DC in human skin and lymph nodes by CD80/CD86-targeted fiber-modified adenovirus-5/3.

Authors:  Rieneke van de Ven; Jelle J Lindenberg; Dinja Oosterhoff; M Petrousjka van den Tol; Rodney A Rosalia; Miho Murakami; Maaike Everts; George L Scheffer; Rik J Scheper; Tanja D de Gruijl; David T Curiel
Journal:  J Immunother       Date:  2009 Nov-Dec       Impact factor: 4.456

4.  High Antigen Processing Machinery component expression in Langerhans cells from melanoma patients' sentinel lymph nodes.

Authors:  Maria Raffaella Romoli; Paola Di Gennaro; Gianni Gerlini; Serena Sestini; Paola Brandani; Soldano Ferrone; Lorenzo Borgognoni
Journal:  Cell Immunol       Date:  2017-08-30       Impact factor: 4.868

5.  Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node.

Authors:  Kim M van Pul; Ronald J C L M Vuylsteke; Rieneke van de Ven; Elisabeth A Te Velde; Emiel J Th Rutgers; Petrousjka M van den Tol; Hein B A C Stockmann; Tanja D de Gruijl
Journal:  J Immunother Cancer       Date:  2019-05-22       Impact factor: 13.751

Review 6.  Unlocking the therapeutic potential of primary tumor-draining lymph nodes.

Authors:  Jossie Rotman; Bas D Koster; Ekaterina S Jordanova; A Marijne Heeren; Tanja D de Gruijl
Journal:  Cancer Immunol Immunother       Date:  2019-04-03       Impact factor: 6.968

7.  Advanced ovarian cancer: Vaccination site draining lymph node as target of immuno-modulative adjuvants in autologous cancer vaccine.

Authors:  Eduardo Lasalvia-Prisco; Emilio Garcia-Giralt; Silvia Cucchi; Jesús Vázquez; Leonard Robinson; John Dalton
Journal:  Biologics       Date:  2007-06

8.  Local delivery of CpG-B and GM-CSF induces concerted activation of effector and regulatory T cells in the human melanoma sentinel lymph node.

Authors:  Mari F C M van den Hout; Berbel J R Sluijter; Saskia J A M Santegoets; Paul A M van Leeuwen; M Petrousjka van den Tol; Alfons J M van den Eertwegh; Rik J Scheper; Tanja D de Gruijl
Journal:  Cancer Immunol Immunother       Date:  2016-03-02       Impact factor: 6.968

9.  High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodes.

Authors:  Rieneke van de Ven; Anna-Larissa N Niemeijer; Anita G M Stam; Sayed M S Hashemi; Christian G Slockers; Johannes M Daniels; Erik Thunnissen; Egbert F Smit; Tanja D de Gruijl; Adrianus J de Langen
Journal:  ERJ Open Res       Date:  2017-05-23

10.  Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway.

Authors:  Kim M van Pul; Ronald J C L M Vuylsteke; Monique T A de Beijer; Rieneke van de Ven; M Petrousjka van den Tol; Hein B A C Stockmann; Tanja D de Gruijl
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.